University of Kansas Medical Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1906-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.kumc.edu
Rural Alliance for Diabetes Prevention
Not Applicable
Not yet recruiting
- Conditions
- PreDiabetes
- Interventions
- Behavioral: Zoom Group Video (GV)Behavioral: Self Directed (SD)
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT06252038
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
Not Applicable
Recruiting
- Conditions
- Walking, DifficultyCardiovascular InjuryStroke
- Interventions
- Other: Leg Cycling ExerciseOther: Gait Training
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT06247553
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Testing Swim Instruction for Autistic Children
Not Applicable
Not yet recruiting
- Conditions
- Autism
- Interventions
- Behavioral: Sensory Enhanced AquaticsBehavioral: Standard Swim Lessons
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT06216613
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
Phase 2
Recruiting
- Conditions
- Recurrent CholangiocarcinomaStage IV Hilar Cholangiocarcinoma AJCC v8Stage IV Intrahepatic Cholangiocarcinoma AJCC v8Metastatic CholangiocarcinomaStage III Hilar Cholangiocarcinoma AJCC v8Locally Advanced CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingProcedure: Positron Emission TomographyBiological: Sacituzumab Govitecan
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT06178588
- Locations
- 🇺🇸
University of Kansas Cancer Center, Kansas City, Kansas, United States
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
Recruiting
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Other: UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT06157164
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
Recruiting
- Conditions
- Inclusion Body Myositis
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06153108
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
Phase 2
Recruiting
- Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8Unresectable Melanoma
- Interventions
- Procedure: Biospecimen CollectionDrug: CyclophosphamideProcedure: EchocardiographyDrug: FludarabineBiological: Interleukin-2Biological: LifileucelProcedure: Magnetic Resonance ImagingProcedure: Multigated Acquisition ScanProcedure: Tumor Resection
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT06151847
- Locations
- 🇺🇸
University of Kansas Cancer Center, Kansas City, Kansas, United States
AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults
Not Applicable
Recruiting
- Conditions
- Brain Aging
- Interventions
- Other: Avocado Group
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT06137339
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
ECoLoGiC Speech Therapy for Everyday Communication in Aphasia
Not Applicable
Completed
- Conditions
- Aphasia
- Interventions
- Behavioral: Expanding Communication and Language Generated in Conversation Treatment
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT06132464
- Locations
- 🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Phase 2
Not yet recruiting
- Conditions
- Stage IV Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone ScanRadiation: BrachytherapyProcedure: Computed TomographyProcedure: Dual X-ray AbsorptiometryRadiation: External Beam Radiation TherapyProcedure: Magnetic Resonance ImagingProcedure: PSMA PET ScanOther: Questionnaire AdministrationDrug: Relugolix
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT06129851
- Locations
- 🇺🇸
University of Kansas Cancer Center, Kansas City, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath